"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Descriptor ID |
D009369
|
MeSH Number(s) |
C04
|
Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 11 | 4 | 15 |
1995 | 10 | 4 | 14 |
1996 | 8 | 1 | 9 |
1997 | 6 | 0 | 6 |
1998 | 3 | 3 | 6 |
1999 | 9 | 2 | 11 |
2000 | 4 | 1 | 5 |
2001 | 12 | 1 | 13 |
2002 | 11 | 8 | 19 |
2003 | 25 | 6 | 31 |
2004 | 21 | 11 | 32 |
2005 | 34 | 4 | 38 |
2006 | 28 | 8 | 36 |
2007 | 30 | 9 | 39 |
2008 | 39 | 10 | 49 |
2009 | 37 | 9 | 46 |
2010 | 34 | 13 | 47 |
2011 | 32 | 10 | 42 |
2012 | 39 | 10 | 49 |
2013 | 44 | 11 | 55 |
2014 | 38 | 11 | 49 |
2015 | 63 | 11 | 74 |
2016 | 43 | 13 | 56 |
2017 | 48 | 7 | 55 |
2018 | 52 | 5 | 57 |
2019 | 46 | 12 | 58 |
2020 | 64 | 6 | 70 |
2021 | 64 | 0 | 64 |
2022 | 48 | 1 | 49 |
2023 | 16 | 0 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Implementation Mapping for Managing Patients at High Risk for Hereditary Cancer. Am J Prev Med. 2024 Mar; 66(3):503-515.
-
A Bayesian framework for pathway-guided identification of cancer subgroups by integrating multiple types of genomic data. Stat Med. 2023 12 10; 42(28):5266-5284.
-
Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance. Cell Rep. 2023 04 25; 42(4):112314.
-
Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell-targeted therapy. JCI Insight. 2023 Mar 22; 8(6).
-
Cancer cachexia: involvement of an expanding macroenvironment. Cancer Cell. 2023 03 13; 41(3):581-584.
-
External Validation of Risk Factors for Unplanned Hospitalization in Older Adults With Advanced Cancer Receiving Chemotherapy. J Natl Compr Canc Netw. 2023 03; 21(3):273-280.e3.
-
Upregulation of sphingosine kinase 1 in response to doxorubicin generates an angiogenic response via stabilization of Snail. FASEB J. 2023 03; 37(3):e22787.
-
Implementing interventions to start HPV vaccination at age 9: Using the evidence we have. Hum Vaccin Immunother. 2023 Dec 31; 19(1):2180250.
-
Causes of Clonal Hematopoiesis: a Review. Curr Oncol Rep. 2023 Mar; 25(3):211-220.
-
Using cognitive interviews to improve a measure of organizational readiness for implementation. BMC Health Serv Res. 2023 Jan 27; 23(1):93.